Pub Date : 2026-01-12DOI: 10.1007/s00203-025-04689-2
Gabriela De Sousa, Jennifer Sánchez, Eduardo Bandeira, Elizabeth Ferrer, Francisco J. Triana-Alonso
Trypanosoma cruzi causes American trypanosomiasis or Chagas Disease, a neglected tropical disease with cardiac, digestive and neurological involvement that can be fatal, and for which there are few effective antiparasitic drugs. EF3 is an elongation factor with ATPase activity present in fungi, which are not present in mammalian; it is essential for protein synthesis in these organisms, this molecule is also present in some protist parasites, so the objective of this work was the determination and characterization of nucleotidases associated with polysomes of T. cruzi. The nucleotidase activity of T. cruzi polysomes was studied and compared with that found in human ribosomes. Epimastigotes of T. cruzi were processed by subcellular fractionation techniques, obtaining the fractions: kinetoplasts (K), polysomal (P) and soluble (S100). The ability to hydrolyze ATP in each fraction was determined measuring the inorganic phosphate (Pi) released. The total ATPase activity was distributed between K (11.6%) and P (9.4%), while S100 did not present activity. The highest specific activity was found in K (116 ± 1 nmol/Pi/mg protein), followed by P (83 ± 3 nmol/Pi/mg protein). The preferential substrate of polysomal nucleotidases was ATP, followed by GTP. Ouabain and vanadate inhibited polysomal ATPase activity by 39% and 68%, respectively. Sequence comparison analysis of EF3 and T. cruzi nucleotidases and molecular modeling were performed, demonstrating that nucleotidase activity does not correspond to a possible EF3 analogue in T. cruzi. Differences with human ribosomal ATPase could be exploited for chemotherapeutic control of the parasite.
{"title":"Determination and characterization of nucleotidases associated to polysomes of Trypanosoma Cruzi","authors":"Gabriela De Sousa, Jennifer Sánchez, Eduardo Bandeira, Elizabeth Ferrer, Francisco J. Triana-Alonso","doi":"10.1007/s00203-025-04689-2","DOIUrl":"10.1007/s00203-025-04689-2","url":null,"abstract":"<div><p><i>Trypanosoma cruzi</i> causes American trypanosomiasis or Chagas Disease, a neglected tropical disease with cardiac, digestive and neurological involvement that can be fatal, and for which there are few effective antiparasitic drugs. EF3 is an elongation factor with ATPase activity present in fungi, which are not present in mammalian; it is essential for protein synthesis in these organisms, this molecule is also present in some protist parasites, so the objective of this work was the determination and characterization of nucleotidases associated with polysomes of <i>T. cruzi.</i> The nucleotidase activity of <i>T. cruzi</i> polysomes was studied and compared with that found in human ribosomes. Epimastigotes of <i>T. cruzi</i> were processed by subcellular fractionation techniques, obtaining the fractions: kinetoplasts (K), polysomal (P) and soluble (S100). The ability to hydrolyze ATP in each fraction was determined measuring the inorganic phosphate (Pi) released. The total ATPase activity was distributed between K (11.6%) and P (9.4%), while S100 did not present activity. The highest specific activity was found in K (116 ± 1 nmol/Pi/mg protein), followed by P (83 ± 3 nmol/Pi/mg protein). The preferential substrate of polysomal nucleotidases was ATP, followed by GTP. Ouabain and vanadate inhibited polysomal ATPase activity by 39% and 68%, respectively. Sequence comparison analysis of EF3 and <i>T. cruzi</i> nucleotidases and molecular modeling were performed, demonstrating that nucleotidase activity does not correspond to a possible EF3 analogue in <i>T. cruzi</i>. Differences with human ribosomal ATPase could be exploited for chemotherapeutic control of the parasite.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00203-025-04671-y
Rafaela Inês de Souza Ladeira Ázar, Yan da Silva Clevelares, Roberta Corsino Ferreira, Riziane Ferreira Gomes, Gabriela Piccolo Maitan-Alfenas, Valéria Monteze Guimarães
Phytases hydrolyze phytic acid (myo-inositol hexakisphosphate), releasing inorganic phosphorus and essential minerals, thereby increasing their bioavailability for animals and humans. However, low native production and the limited stability of wild-type enzymes hinder their industrial applications. In this study, the PHY7227 gene from Talaromyces pinophilus was cloned and expressed in Komagataella phaffii, yielding a recombinant phytase with a specific activity of 371.29 U/mg. The identity of this phytase was confirmed by SDS-PAGE and LC-MS/MS. The recombinant phytase exhibited a molecular mass of ~ 75 kDa, maximum activity at pH 5.5 and at 55 °C and 60 °C and showed higher specificity for sodium phytate, exhibiting Km app and Vmax app values of 0.947 mM and 7.67 µmol×s− 1, respectively, against this substrate. The enzyme showed significant thermostability at 50 °C and it was not inhibited by EDTA, DTT, or β-mercaptoethanol. In order to immobilize the phytase using the cross-linked enzyme aggregate (CLEA), 70% (v/v) isopropanol provided the highest CLEA immobilization yield, 83%, and activity recovery of 70.8%. Compared to the free form, the immobilized phytase exhibited enhanced thermostability at 50 °C and a broader pH activity range. The immobilized phytase maintained over 60% of its initial activity after ten cycles of reuse in sodium phytate hydrolysis. These results demonstrate the effectiveness of CLEA immobilization for the recombinant phytase and highlight its potential for industrial applications, especially in animal feed production.
{"title":"Characterization and CLEA immobilization of Talaromyces pinophilus phytase produced in Komagataella phaffii","authors":"Rafaela Inês de Souza Ladeira Ázar, Yan da Silva Clevelares, Roberta Corsino Ferreira, Riziane Ferreira Gomes, Gabriela Piccolo Maitan-Alfenas, Valéria Monteze Guimarães","doi":"10.1007/s00203-025-04671-y","DOIUrl":"10.1007/s00203-025-04671-y","url":null,"abstract":"<div><p>Phytases hydrolyze phytic acid (myo-inositol hexakisphosphate), releasing inorganic phosphorus and essential minerals, thereby increasing their bioavailability for animals and humans. However, low native production and the limited stability of wild-type enzymes hinder their industrial applications. In this study, the <i>PHY7227</i> gene from <i>Talaromyces pinophilus</i> was cloned and expressed in <i>Komagataella phaffii</i>, yielding a recombinant phytase with a specific activity of 371.29 U/mg. The identity of this phytase was confirmed by SDS-PAGE and LC-MS/MS. The recombinant phytase exhibited a molecular mass of ~ 75 kDa, maximum activity at pH 5.5 and at 55 °C and 60 °C and showed higher specificity for sodium phytate, exhibiting <i>K</i><sub><i>m app</i></sub> and <i>V</i><sub><i>max app</i></sub> values of 0.947 mM and 7.67 µmol×s<sup>− 1</sup>, respectively, against this substrate. The enzyme showed significant thermostability at 50 °C and it was not inhibited by EDTA, DTT, or β-mercaptoethanol. In order to immobilize the phytase using the cross-linked enzyme aggregate (CLEA), 70% (v/v) isopropanol provided the highest CLEA immobilization yield, 83%, and activity recovery of 70.8%. Compared to the free form, the immobilized phytase exhibited enhanced thermostability at 50 °C and a broader pH activity range. The immobilized phytase maintained over 60% of its initial activity after ten cycles of reuse in sodium phytate hydrolysis. These results demonstrate the effectiveness of CLEA immobilization for the recombinant phytase and highlight its potential for industrial applications, especially in animal feed production.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Helicobacter pylori is a major human pathogen responsible for chronic gastritis, peptic ulcers, and gastric cancer. Its persistence is facilitated by a complex arsenal of virulence factors, including the CagA oncoprotein, the VacA toxin, adhesins, and the ability to form biofilms. While the roles of individual factors are well-studied, the integrated mechanisms by which they collectively drive carcinogenesis remain a critical knowledge gap. This review integrates evidence showing that CagA delivery and type IV secretion–dependent signals create a transient, infection-driven BRCAness (BRCA1/2 pathway deficiency) state, which is a homologous recombination DNA repair deficiency, promoting error-prone repair and genomic instability. Concurrently, CagA-independent pathways, such as T4SS-mediated ADP-heptose delivery and reactive oxygen species generation, contribute to DNA double-strand breaks. The infection further impairs host defenses by disrupting tumor suppressor pathways such as p53, dysregulating immune signaling of NF-κB and JAK/STAT, which results in immune evasion through arginine depletion and impaired antigen presentation. By elucidating the coordinated interplay among virulence factors, DNA damage response impairment, and immune modulation, this review highlights potential intervention nodes that may help disrupt persistent infection and ultimately reduce the risk of H. pylori-associated gastric cancer.
{"title":"A vicious cycle inducer in gastric pathogenesis: implication of Helicobacter pylori","authors":"Amiratabak Rajaei, Pooya Mahdavi, Rojan Chimehrad, Mehrasa Zakeri, Zahra Sadeghloo, Ehsan Nazemalhosseini Mojarad","doi":"10.1007/s00203-025-04662-z","DOIUrl":"10.1007/s00203-025-04662-z","url":null,"abstract":"<div><p><i>Helicobacter pylori</i> is a major human pathogen responsible for chronic gastritis, peptic ulcers, and gastric cancer. Its persistence is facilitated by a complex arsenal of virulence factors, including the CagA oncoprotein, the VacA toxin, adhesins, and the ability to form biofilms. While the roles of individual factors are well-studied, the integrated mechanisms by which they collectively drive carcinogenesis remain a critical knowledge gap. This review integrates evidence showing that CagA delivery and type IV secretion–dependent signals create a transient, infection-driven BRCAness (BRCA1/2 pathway deficiency) state, which is a homologous recombination DNA repair deficiency, promoting error-prone repair and genomic instability. Concurrently, CagA-independent pathways, such as T4SS-mediated ADP-heptose delivery and reactive oxygen species generation, contribute to DNA double-strand breaks. The infection further impairs host defenses by disrupting tumor suppressor pathways such as p53, dysregulating immune signaling of NF-κB and JAK/STAT, which results in immune evasion through arginine depletion and impaired antigen presentation. By elucidating the coordinated interplay among virulence factors, DNA damage response impairment, and immune modulation, this review highlights potential intervention nodes that may help disrupt persistent infection and ultimately reduce the risk of <i>H. pylori</i>-associated gastric cancer.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00203-025-04701-9
K. Balakrishna, G. Naveena, J. Joseph Kingston
Postbiotics, defined as preparations containing inactivated microbial cells, cell fragments, and bioactive metabolites are increasingly recognized as next-generation functional ingredients owing to their superior safety, stability, and regulatory flexibility compared with live probiotics. Their capacity to modulate immune responses, exert antimicrobial effects, enhance metabolic homeostasis, and strengthen gut-barrier integrity without the risks associated with microbial viability or translocation makes them highly suitable for applications in foods, pharmaceuticals, animal feed, and aquaculture systems. Nevertheless, despite rapid commercial expansion, the scientific foundations and industrial processes required for consistent postbiotic production remain poorly integrated, with limited standardization across strain selection, inactivation strategies, and analytical quality metrics. This review highlights recent developments in targeted strain selection, controlled fermentation strategies, downstream processing innovations, and emerging thermal and non-thermal inactivation methods designed to preserve essential structural and metabolic components. It further examines downstream stabilization approaches such as microencapsulation, freeze-drying, and advanced filtration techniques that enhance product functionality and shelf stability. In addition, the review consolidates the expanding portfolio of commercial postbiotic formulations, outlines the microbial species employed, and summarizes the evidence supporting their health benefits across diverse application sectors. Particular emphasis is placed on technological innovations, including precision inactivation tools and multi-omics-driven characterization methods, which are progressively transforming postbiotics from conceptual laboratory entities into scalable industrial solutions. The review also highlights persistent challenges related to process standardization, compositional consistency, and global regulatory alignment, and proposes a structured framework to guide future research and product development. Overall, this work provides an integrated and future-oriented perspective intended to support researchers, industry stakeholders, and regulatory agencies in advancing the science, technology, and commercialization of safe, stable, and efficacious postbiotic products.
{"title":"Postbiotics at the interface of microbial biotechnology and therapeutics: industrial production, functional mechanisms, and clinical potentials","authors":"K. Balakrishna, G. Naveena, J. Joseph Kingston","doi":"10.1007/s00203-025-04701-9","DOIUrl":"10.1007/s00203-025-04701-9","url":null,"abstract":"<div><p>Postbiotics, defined as preparations containing inactivated microbial cells, cell fragments, and bioactive metabolites are increasingly recognized as next-generation functional ingredients owing to their superior safety, stability, and regulatory flexibility compared with live probiotics. Their capacity to modulate immune responses, exert antimicrobial effects, enhance metabolic homeostasis, and strengthen gut-barrier integrity without the risks associated with microbial viability or translocation makes them highly suitable for applications in foods, pharmaceuticals, animal feed, and aquaculture systems. Nevertheless, despite rapid commercial expansion, the scientific foundations and industrial processes required for consistent postbiotic production remain poorly integrated, with limited standardization across strain selection, inactivation strategies, and analytical quality metrics. This review highlights recent developments in targeted strain selection, controlled fermentation strategies, downstream processing innovations, and emerging thermal and non-thermal inactivation methods designed to preserve essential structural and metabolic components. It further examines downstream stabilization approaches such as microencapsulation, freeze-drying, and advanced filtration techniques that enhance product functionality and shelf stability. In addition, the review consolidates the expanding portfolio of commercial postbiotic formulations, outlines the microbial species employed, and summarizes the evidence supporting their health benefits across diverse application sectors. Particular emphasis is placed on technological innovations, including precision inactivation tools and multi-omics-driven characterization methods, which are progressively transforming postbiotics from conceptual laboratory entities into scalable industrial solutions. The review also highlights persistent challenges related to process standardization, compositional consistency, and global regulatory alignment, and proposes a structured framework to guide future research and product development. Overall, this work provides an integrated and future-oriented perspective intended to support researchers, industry stakeholders, and regulatory agencies in advancing the science, technology, and commercialization of safe, stable, and efficacious postbiotic products.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<div><p>Reducing malaria transmission and the prospects for vector control include multi-pronged strategies, such as interrupting the parasite cycle in both vectors and mosquitoes. Effective vector control remains essential to prevent malaria transmission. This is all the more important as problems such as resistance to insecticides and the lack of a highly effective malaria vaccine remain. New generation vector control measures and optimised products are essential to address the public health needs for malaria eradication. Strategies to reduce malaria transmission include the use of insecticide-treated nets (ITNs), indoor residual spraying (IRS) and other measures. Recent studies have shown that <i>Wolbachia pipientis</i>, a bacterium that acts as an intracellular endosymbiotic in host cells, is becoming increasingly popular as a new method of control for <i>Anopheles</i> mosquitoes, both for cytoplasmic incompatibility and for pathogen blocking. <i>Anopheles gambiae</i>, the infection rate ranged from 8 to 24% in the wild population of the same study in the case of <i>An</i>. <i>coulzzi</i> (WAnga) in Ghana, with a prevalence of 4%. Various studies have successfully identified <i>Wolbachia</i> in several species of <i>Anopheles</i>. A highly infected <i>Anopheles species A</i> population in the Democratic Republic of the Congo (DRC) showed a 91% infection rate (strain <i>wAnsA</i>). Broader surveys list additional species hosting natural <i>Wolbachia</i>, including <i>An. funestus</i>, <i>An. moucheti</i>, <i>An. melas</i>, <i>An. nili</i>, <i>An. coustani</i>, <i>An. dirus</i>, <i>An. baimaii</i>, <i>An. hyrcanus</i>, and <i>An. sinensis</i>, among others, totalling around 31 <i>Anopheles</i> species. In <i>Anopheles stephensi</i>, researchers achieved stable maternal transmission of the <i>wPip</i> strain with a 100% infection frequency in the transinfected line across generations. The infection caused nearly complete cytoplasmic incompatibility (CI) and moderate fitness costs. Previous experimental infections using the <i>wAlbB</i> strain in <i>An. stephensi</i> similarly established CI and partial protection against <i>Plasmodium</i> infection. <i>Wolbachia</i> has been detected naturally at low prevalence (~ 1.4%) in field-collected <i>An. culicifacies</i> samples in India. However, these infections are often rare and may not lead to a high blocking effect of the pathogens. Despite the notable progress in demonstrating the CI and moderate inhibitory effect of the pathogen in several <i>Anopheles</i> trans-infected lines, the remaining setbacks include persistent, mother-transmitted infection with a high population replacement or suppression potential that will be relevant for widespread use. This comprehensive evaluation identified the need for further research on host-symbiotic interactions, improved genetic engineering tools and comprehensive long-term field evaluations to fully realise the potential of <i>Wolbachia</i> as a vector contr
{"title":"The symbiotic Wolbachia in Anopheles and its role in reducing the transmission of Plasmodium: updates and prospects","authors":"Rohit Nehra, Suman Dhanda, Kuldeep Singh, Himmat Singh, Praveen Kumar Bharti","doi":"10.1007/s00203-025-04617-4","DOIUrl":"10.1007/s00203-025-04617-4","url":null,"abstract":"<div><p>Reducing malaria transmission and the prospects for vector control include multi-pronged strategies, such as interrupting the parasite cycle in both vectors and mosquitoes. Effective vector control remains essential to prevent malaria transmission. This is all the more important as problems such as resistance to insecticides and the lack of a highly effective malaria vaccine remain. New generation vector control measures and optimised products are essential to address the public health needs for malaria eradication. Strategies to reduce malaria transmission include the use of insecticide-treated nets (ITNs), indoor residual spraying (IRS) and other measures. Recent studies have shown that <i>Wolbachia pipientis</i>, a bacterium that acts as an intracellular endosymbiotic in host cells, is becoming increasingly popular as a new method of control for <i>Anopheles</i> mosquitoes, both for cytoplasmic incompatibility and for pathogen blocking. <i>Anopheles gambiae</i>, the infection rate ranged from 8 to 24% in the wild population of the same study in the case of <i>An</i>. <i>coulzzi</i> (WAnga) in Ghana, with a prevalence of 4%. Various studies have successfully identified <i>Wolbachia</i> in several species of <i>Anopheles</i>. A highly infected <i>Anopheles species A</i> population in the Democratic Republic of the Congo (DRC) showed a 91% infection rate (strain <i>wAnsA</i>). Broader surveys list additional species hosting natural <i>Wolbachia</i>, including <i>An. funestus</i>, <i>An. moucheti</i>, <i>An. melas</i>, <i>An. nili</i>, <i>An. coustani</i>, <i>An. dirus</i>, <i>An. baimaii</i>, <i>An. hyrcanus</i>, and <i>An. sinensis</i>, among others, totalling around 31 <i>Anopheles</i> species. In <i>Anopheles stephensi</i>, researchers achieved stable maternal transmission of the <i>wPip</i> strain with a 100% infection frequency in the transinfected line across generations. The infection caused nearly complete cytoplasmic incompatibility (CI) and moderate fitness costs. Previous experimental infections using the <i>wAlbB</i> strain in <i>An. stephensi</i> similarly established CI and partial protection against <i>Plasmodium</i> infection. <i>Wolbachia</i> has been detected naturally at low prevalence (~ 1.4%) in field-collected <i>An. culicifacies</i> samples in India. However, these infections are often rare and may not lead to a high blocking effect of the pathogens. Despite the notable progress in demonstrating the CI and moderate inhibitory effect of the pathogen in several <i>Anopheles</i> trans-infected lines, the remaining setbacks include persistent, mother-transmitted infection with a high population replacement or suppression potential that will be relevant for widespread use. This comprehensive evaluation identified the need for further research on host-symbiotic interactions, improved genetic engineering tools and comprehensive long-term field evaluations to fully realise the potential of <i>Wolbachia</i> as a vector contr","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
An experiment was conducted to isolate, identify, and characterize the soil bacteria capable of biodegrading untreated Low Density Polyethylene (LDPE) from selected locations of municipal corporation dumping stations in Thoothukudi, Southeast coast of Tamil Nadu, India. A total of 29 distinct bacteria were isolated using Tryptic Soya Agar (TSA) after enrichment of soil samples from the selected sites. Of which, two isolates produced maximum zone of clearance during screening and formed biofilm after 21 days of incubation. The 16 S rRNA sequencing confirmed that the isolates were identified as Paenibacillus timonensis (PX106822) and Cupriavidus nantongensis (PX106762) which resulted in the weight reductions of 3.15% and 1.83% respectively on untreated LDPE after 30 days of incubation. During degradation, the pH of the Mineral Salt Medium (MSM) increased from 6.73 to 8.06 and 8.11 respectively by the two isolates. In the present study, it was observed that the two isolates had increased viable cell count of 7.07 × 108 and 3.83 × 107 CFU/ml respectively with the initial attachment onto the LDPE films followed by biofilm formation, which favoured biodegradation of LDPE. Fourier Transform Infrared (FTIR) spectroscopy and Field Emission Scanning Electron Microscopy (FE-SEM) analysis also confirmed that the two isolates had adhered and attacked on the surface of LDPE film thus serving as evidence for bacterial degradation of LDPE. This study concluded that the isolates had more capability in LDPE biodegradation and will serve as a baseline data for plastic litter management.
{"title":"Indigenous LDPE degradation bacteria from plastic dumping soils of Thoothukudi coast: isolation, characterization and degradation efficiency","authors":"Rajendran Jagatheeswari Abisha, Velu Rani, Durairaj Manimekalai, Muthiah Muruganantham","doi":"10.1007/s00203-025-04666-9","DOIUrl":"10.1007/s00203-025-04666-9","url":null,"abstract":"<div><p>An experiment was conducted to isolate, identify, and characterize the soil bacteria capable of biodegrading untreated Low Density Polyethylene (LDPE) from selected locations of municipal corporation dumping stations in Thoothukudi, Southeast coast of Tamil Nadu, India. A total of 29 distinct bacteria were isolated using Tryptic Soya Agar (TSA) after enrichment of soil samples from the selected sites. Of which, two isolates produced maximum zone of clearance during screening and formed biofilm after 21 days of incubation. The 16 S rRNA sequencing confirmed that the isolates were identified as <i>Paenibacillus timonensis</i> (PX106822) and <i>Cupriavidus nantongensis</i> (PX106762) which resulted in the weight reductions of 3.15% and 1.83% respectively on untreated LDPE after 30 days of incubation. During degradation, the pH of the Mineral Salt Medium (MSM) increased from 6.73 to 8.06 and 8.11 respectively by the two isolates. In the present study, it was observed that the two isolates had increased viable cell count of 7.07 × 10<sup>8</sup> and 3.83 × 10<sup>7</sup> CFU/ml respectively with the initial attachment onto the LDPE films followed by biofilm formation, which favoured biodegradation of LDPE. Fourier Transform Infrared (FTIR) spectroscopy and Field Emission Scanning Electron Microscopy (FE-SEM) analysis also confirmed that the two isolates had adhered and attacked on the surface of LDPE film thus serving as evidence for bacterial degradation of LDPE. This study concluded that the isolates had more capability in LDPE biodegradation and will serve as a baseline data for plastic litter management.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 2","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}